Management of anaemia in prostate cancer.
Anaemia is a frequent complication of prostate cancer and of its treatments. In Europe prostate cancer accounts for the 10.8% of all malignant neoplasms. Iatrogenic hypogonadism and age-related physiologic changes along with nutritional deficits contribute to increase prevalence of prostate cancer related anaemia. The reason of the present review is to provide clinicians with all aspects of a frequent and multifactorial co-morbidity, whose effects are often underestimated. Erythropoiesis pathology and causes of anaemia in prostate cancer are reviewed. Critical issues of clinical management of anaemia in prostate cancer are discussed.
Colloca
Giuseppe
G
Division of Medical Oncology, ASL-1 Imperiese, Ospedale Civile, Sanremo, Italy.
Venturino
Antonella
A
Vitucci
Pasquale
P
Gianni
Walter
W
D000740:Anemia / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D004920:Erythropoiesis; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000150:complications* / Q000523:psychology; D011788:Quality of Life